Public beta© 2026 Adaptrex, LLC
Public beta© 2026 Adaptrex, LLC
Federal grant · project grant (b)
Mobile Technology for Reducing and Preventing Adolescent Suicide - Abstract Suicide Is a Top Two Cause of Death in the Us for Adolescents and Suicide Rates Among Youth Have Steadily Increased. Despite This, There Is a Paucity of Research on Mobile Technology Designed to Reduce Suicide Attempts Among Youth. in This Phase I Sbir Application Oui Therapeutics, LLC Proposes a Project to: 1) Create a Beta Version of Aviva-y for Youth (ages 13 - 17); and 2) to Test the Feasibility and Acceptability of the Beta Version of Aviva-y in a Single-group, Open-label Trial. Successful Execution of the Goals of This Phase I Project Will Generate a Version of Aviva-y That Is Ready to Be Tested for Efficacy With Stabilized Patients in a Clinical Trial. in the Long Term, This Project Will Have a Beneficial Impact on the Field of Youth Suicide Prevention Through the Development of Mobile Technology Designed to Advance the Delivery and Dissemination of Effective Interventions.
Committed
$398,984
Paid out
$242.7K
61%
Committed, not yet paid
$156.3K
39%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…